Product: Pioglitazone Tablets USP, 45 mg, 500 count bottles, Distributed by: Aurobindo Pharma USA, Inc., East Windsor, NJ -- NDC 57237-221-05
Reason for recall: Superpotent and Failed Tablet/Capsule Specifications
Recall initiated: 20211229
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated